ADRIENNE WARREN: Open Payments
NPI 1750802369 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$904 in 36 payments from 10 companies in 2025. Trend: 2023 $305 · 2024 $809 · 2025 $904
Food & beverage: $904
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $496 |
| Janssen Biotech, Inc. | 4 | $120 |
| PFIZER INC. | 4 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
| Ardelyx, Inc. | 2 | $45 |
| Lilly USA, LLC | 2 | $43 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Celltrion USA Inc. | 1 | $18 |
Products named: SKYRIZI, RINVOQ, TREMFYA, LINZESS, VELSIPITY, ENTYVIO, IBSRELA, OMVOH.
Industry payments across VA — which companies pay providers there.
